Hematopoietic Stem Cell Transplantation for Homozygous β Thalassemia and β Thalassemia/Hemoglobin E Patients from Haploidentical Donors

Thalassemia free survival after allogeneic stem cell transplantation (SCT) is about 80–90% with either matched related or unrelated donors. However, the probability of finding a HLA-compatible donor is less than 50%. We explored the use of a mismatched related (“Haplo-”) donor. All patients received...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bone Marrow Transplant
Autori principali: Anurathapan, U, Hongeng, S, Pakakasama, S, Sirachainan, N, Songdej, D, Chuansumrit, A, Charoenkwan, P, Jetsrisuparb, A, Sanpakit, K, Rujkijyanont, P, Meekaewkunchorn, A, Lektrakul, Y, Iamsirirak, P, Surapolchai, P, Satayasai, W, Sirireung, S, Sruamsiri, R, Wahidiyat, PA, Ungkanont, A, Issaragrisil, S, Andersson, BS
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957689/
https://ncbi.nlm.nih.gov/pubmed/26878659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi